Home > Insider Trading > Filing (0001140361-17-018903)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
812796	Soligenix Inc.	SNGX	Pharmaceutical Preparations (2834)	411505029

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1091823	J Randal Kirk	C/O Third Security, Llc 1881 Grove Avenue Radford VA 24141		No	No	Yes	No
1356090	Intrexon Corp	C/O Legal Department 20374 Seneca Meadows Parkway Germantown MD 20876		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-04	250,000	$0.80	583,334	No	4	X	Indirect	by NRM VII Holdings
Common Stock	Disposition	2017-05-04	49,875	$4.01	533,459	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2017-05-04	11,739	$2.97	521,720	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2017-05-05	71,607	$2.70	450,113	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2017-05-08	9,695	$2.54	440,418	No	4	S	Indirect	by NRM VII Holdings
Common Stock	Disposition	2017-05-04	2,278	$2.97	101,171	No	4	S	Indirect	by Intrexon
Common Stock	Disposition	2017-05-05	13,893	$2.70	87,278	No	4	S	Indirect	by Intrexon
Common Stock	Disposition	2017-05-08	1,881	$2.54	85,397	No	4	S	Indirect	by Intrexon

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	by NRM VII Holdings
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by NRM VII Holdings
No	4	S	Indirect	by Intrexon
No	4	S	Indirect	by Intrexon
No	4	S	Indirect	by Intrexon

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Disposition	2017-05-04	250,000	$0.00	250,000	$0.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-06-25	2018-06-25	No	4	X	Indirect

Footnotes

The indicated share amount is reflective of a 1:10 reverse stock split effected by the issuer on October 7, 2016.
Shares surrendered to the issuer in order to satisfy the exercise price in connection with the cashless exercise of a warrant to purchase 250,000 shares of common stock of the issuer.
Pursuant to a joint selling program, NRM VII Holdings I, LLC ("NRM VII Holdings") and Intrexon Corporation ("Intrexon") sold shares on a pro rata basis.
Randal J. Kirk controls NRM VII Holdings. Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d- 3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon. Shares held by Intrexon may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.